Our

Pipeline

Indication            Target             Mode of Action   

Oncology

STING

Agonist

 IND enabling

Inflammation

STING

Antagonist

Lead Generation stage

Oncology

ACSS2

Inhibitor

Candidate Selection stage

Oncology

TDO/IDO

Inhibitor

IND enabling stage

Oncology

HPK1

Inhibitor

Lead Generation stage

Lead Generation stage

Lead Generation

 Feasibility       

Candidate Selection

IND Enabling